These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Preparation of heart valve scaffold and cell seeding]. Long L; Wu C; Pan L; Qi X; Hong T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443 [TBL] [Abstract][Full Text] [Related]
5. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
6. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110 [TBL] [Abstract][Full Text] [Related]
9. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. Taylor PM; Allen SP; Dreger SA; Yacoub MH J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719 [TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
11. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model]. Leyh R; Wilhelmi M; Haverich A; Mertsching H Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763 [TBL] [Abstract][Full Text] [Related]
12. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912 [TBL] [Abstract][Full Text] [Related]
13. Recellularization of heart valve grafts by a process of adaptive remodeling. Elkins RC; Goldstein S; Hewitt CW; Walsh SP; Dawson PE; Ollerenshaw JD; Black KS; Clarke DR; O'brien MF Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):87-92. PubMed ID: 11805955 [TBL] [Abstract][Full Text] [Related]
14. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study. Hong H; Dong N; Shi J; Chen S; Guo C; Hu P; Qi H Artif Organs; 2009 Jul; 33(7):554-8. PubMed ID: 19566733 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of amphotericin B for fibroblasts in human heart valve leaflets. Brockbank KG; Dawson PE Cryobiology; 1993 Feb; 30(1):19-24. PubMed ID: 8440126 [TBL] [Abstract][Full Text] [Related]
17. Protocols for thawing and cryoprotectant dilution of heart valves. Armitage WJ; Dale W; Alexander EA Cryobiology; 2005 Feb; 50(1):17-20. PubMed ID: 15710365 [TBL] [Abstract][Full Text] [Related]